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Abstract
Background: Previous genome-wide association studies for type 2 diabetes susceptibility genes have confirmed
that a common variant, rs9939609, in the fat mass and obesity associated (FTO) gene region is associated with
body mass index (BMI) in European children and adults. A significant association of the same risk allele has been
described in Asian adult populations, but the results are conflicting. In addition, no replication studies have been
conducted in children and adolescents of Asian ancestry.
Methods: A population-based survey was carried out among 3503 children and adolescents (6-18 years of age) in
Beijing, China, including 1229 obese and 2274 non-obese subjects. We investigated the association of rs9939609
with BMI and the risk of obesity. In addition, we tested the association of rs9939609 with weight, height, waist
circumference, waist-to-height ratio, fat mass percentage, birth weight, blood pressure and related metabolic traits.
Results: We found significant associations of rs9939609 variant with weight, BMI, BMI standard deviation score
(BMI-SDS), waist circumference, waist-to-height ratio, and fat mass percentage in children and adolescents (p for
trend = 3.29 × 10
-5, 1.39 × 10
-6, 3.76 × 10
-6, 2.26 × 10
-5, 1.94 × 10
-5, and 9.75 × 10
-5, respectively). No significant
associations were detected with height, birth weight, systolic and diastolic blood pressure and related metabolic
traits such as total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol and fasting plasma glucose (all p >
0.05). Each additional copy of the rs9939609 A allele was associated with a BMI increase of 0.79 [95% Confidence
interval (CI) 0.47 to 1.10] kg/m
2, equivalent to 0.25 (95%CI 0.14 to 0.35) BMI-SDS units. This rs9939609 variant is
significantly associated with the risk of obesity under an additive model [Odds ratio (OR) = 1.29, 95% CI 1.11 to
1.50] after adjusting for age and gender. Moreover, an interaction between the FTO rs9939609 genotype and
physical activity (p < 0.001) was detected on BMI levels, the effect of rs9939609-A allele on BMI being (0.95 ± 0.10),
(0.77 ± 0.08) and (0.67 ± 0.05) kg/m
2, for subjects who performed low, moderate and severe intensity physical
activity.
Conclusion: The FTO rs9939609 variant is strongly associated with BMI and the risk of obesity in a population of
children and adolescents in Beijing, China.
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The increasing prevalence of obesity among adults and
children as well as related conditions including type 2
diabetes mellitus [1], cardiovascular diseases [2], hyper-
tension [2], and stroke [3] have become major health
concerns. In China, the nationwide prevalence of over-
weight and obesity among adults has been estimated to
be 22.8% and 7.1%, respectively [4]. A dramatic increase
in the number of overweight and obese children ages 7-
18 years has been observed; a recent study reported that
in northern coastal cities, the combined prevalence had
reached 32.5% for boys and 17.6% for girls in 2005 [5].
Large population-based studies have been conducted to
identify common genetic variants that contribute to obe-
sity. Several promising genes have been reported to be
associated with a variation in body mass index (BMI) in
a monogenic or polygenic manner: proprotein conver-
tase subtilisin/kexin type 1 (PCSK1) [6], melanocortin 4
receptor (MC4R) [7], catenin beta-like 1 (CTNNBL1)
[8], ectonucleotide pyrophosphatase 1 (ENPP1)[ 9 ] ,a n d
beta 2-adrenergic receptor (ADRB2)[ 1 0 ] .Ap r e v i o u s l y
reported population-based meta-study involving as
many as 38759 individuals implemented a genome-wide
search for type 2 diabetes susceptibility genes. Frayling
et al. [11] identified a common variant (rs9939609) in
the fat mass and obesity associated (FTO) gene region
that represents a T to A change in the first intron of
the FTO gene on chromosome 16. They found that
there were significant associations of this single nucleo-
tide polymorphism (SNP) with BMI (p =3×1 0
-35)a n d
the risk of obesity [Odds ratio (OR) = 1.67, 95% Confi-
dence interval (CI) 1.47 to 1.89, p =1×1 0
-14 for the
homozygous condition] in a European adult population.
The A allele was also associated with an increased BMI
in European children from age 7 and older (e.g., at age
11 years, p =7×1 0
-9), and conferred an increased risk
of childhood obesity (e.g., OR per A allele at age 11
years = 1.35, 95% CI 1.14 to 1.61, p =6×1 0
-4)[ 1 1 ] .
However, replication studies in Asian adult populations
yielded inconsistent results. Li et al. [12] reported lack
of association of FTO rs9939609 with risk of obesity in
a Chinese population (n = 3210, p = 0.96). Subsequently,
Chang et al. [13] reported a positive association of
rs9939609 with the risk of obesity and BMI in a popula-
tion of Taiwan, China (n = 2248, p =7×1 0
-4). Hotta et
al. [14] reported that the FTO rs9939609 variant is asso-
ciated with severe obesity in the Japanese (n = 2454,
p =2×1 0
-5), and a study from Singapore (n = 2919)
also reported significant associations of rs9939609 with
BMI and obesity (p < 0.0001) [15].
To date, there are no replication studies reported in
children and adolescents of Asian ancestry. We geno-
typed rs9939609 in children and adolescents that
participated in the epidemiological Beijing Child and
Adolescent Metabolic Syndrome (BCAMS) study to
assess the association of this SNP with BMI and related
traits. We tested the association of rs9939609 with BMI
as a continuous trait and with the risk of obesity as a
dichotomised trait. Other obesity-related anthropometric
and metabolic parameters were also tested for their
association with rs9939609.
Methods
Subjects
Subjects were recruited from the cross-sectional popula-
tion-based Beijing Child and Adolescent Metabolic Syn-
d r o m e( B C A M S )s t u d y[ 1 6 ] .T h es t u d yi n c l u d e d
completion of a questionnaire, a medical examination,
anthropometric measurements, and finger capillary
blood tests from a representative sample of Beijing
school-age children (n = 19593, ages 6-18 years, 50%
boys) between April and October 2004. Anthropometric
measurements included weight, height, waist circumfer-
ence (WC), and fat mass percentage (FMP). BMI (equal
to weight/height
2) and FMP were used as measures of
general adiposity, whereas WC and waist-to-height ratio
(WHtR, equal to WC/height) were used as measures of
central adiposity.
The questionnaires were completed by parents or
guardians if the participant was 12 years or younger and
by the subject if the participant was 13 years or older.
Information regarding birth weight and physical activity
were collected. The estimation of physical activity was
recorded as the total days per week with at least 30
mins per day participating in extracurricular physical
activities such as cycling, roller-skating, running, swim-
ming, dancing, team sports and tennis, etc.. The inten-
sity of physical activity was divided into 3 categories as
low (< 3 days/week), moderate (3-5 days/week) and
severe (≥ 5 days/week).
Within this large group of school-age children, 4500
were screened out as the presence of any one of the fol-
lowing traits: overweight based on BMI standards,
increased cholesterol (≥ 5.2 mM), increased triglycerides
(≥ 1.7 mM) or increased glucose (≥ 5.6 mM). A parallel
reference population of 1045 school-age children was
also studied. Within these two groups, 2544 (BCAMS)
and 981 (reference) children and adolescents were
recruited for blood samples [17]. Of the 3525 total sub-
jects, BMI values or genotyping information were not
available for 22 subjects, and these individuals’ records
were deleted from the database. In our study, 1229
obese children (786 boys, 64.0%) and 2274 non-obese
(including normal and overweight) children (995 boys,
43.8%) were diagnosed by the Chinese age- and gender-
specific BMI standards [18]. The BCAMS study was
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review board of the Capital Institute of Pediatrics (CIP).
All participating children and adolescents as well as
their parents gave written informed consent under pro-
tocols provided by the CIP that clearly stated that blood
samples would be used for scientific research purposes,
including genetic studies. A health questionnaire was
administered to each participant at the same time.
Measurement of anthropometric parameters
All instruments were validated following the manufac-
turers’ protocols [19]. Height without shoes was mea-
sured using wall-mounted stadiometers to the nearest
0.1 cm. Body weight was measured with underwear and
no shoes to the nearest 0.1 kg using beam scales with a
maximum weight of 140 kg. BMI (kg/m
2) was calculated
as body weight/height
2. BMI standard deviation score
(BMI-SDS) for each participant was calculated based on
Chinese National Survey on Students Constitution and
Health in 2000[18]. WC was measured midway between
the lowest rib and the superior border of the iliac crest
with an inelastic measuring tape at the end of normal
expiration to the nearest 0.1 cm. FMP was assessed by
bioelectrical impedance analysis (TANITA TBF-300A).
Blood pressure (BP) was measured with mercury man-
ometer. Systolic BP (SBP) was indicated by Korotkoff’s
first phase and diastolic BP (DBP) by Korotkoff’sf o u r t h
phase.
Fasting plasma glucose (FPG) was determined by the
glucose oxidase method. Serum total cholesterol (TC)
and triglyceride (TG) concentrations were determined
using standard enzymatic methods. HDL-cholesterol
(HDL-C) and LDL-cholesterol (LDL-C) were measured
directly. The serum lipid levels and FPG were assayed
using the Hitachi 7060C Automatic Biochemistry Analy-
sis System.
Genotyping
The rs9939609 SNP of the FTO gene was genotyped by
allele-specific real-time polymerase chain reaction (RT-
PCR) [20] using an ABI 5700 Real Time PCR Instru-
ment (Applied Biosystems, Foster City, California,
United States). Genomic DNA was isolated from per-
ipheral white blood cells using the salt fractionation
method. DNA samples were genotyped for a single
SNP using an equal aliquot of sample in two allele-spe-
cific PCR reactions, each containing one allele-specific
primer (AGACTATCCAAGTGCATCACA or AGAC-
TATCCAAGTGCATCACT) and a common primer
(ATTCTAGGTTCCTTGCGACT). PCR reactions with
an allele-specific primer that is mismatched to the tem-
plate alleles will be prevented or delayed when monitored
in real-time with SYBR Green I®. For each amplification,
a fluorescence threshold near the baseline fluorescence
was used to calculate a cycle threshold (Ct) value. This
value was then used to determine the genotype of the
sample. PCR was carried out on a GeneAmp 5700
Sequence Detector with an enzyme heat-activation step
of 12 min at 95°C, followed by 45 cycles of two-step
amplification (30 seconds at 95°C, 30 seconds at 58°C and
an on-board dissociation run from 60°C to 95°C). The
genotype was determined from the Ct values obtained
with the GeneAmp 5700 SDS software. The genotyping
call rate was 95.73% for the cohort after the first genotyp-
ing reaction, and we obtained 99.97% of the samples’ gen-
otypes by re-genotyping. We estimated the genotyping
error rate at < 1% by validating 100 random samples of
known genotype in additional reactions.
Statistical analysis
Quantitative variables were expressed as means ± stan-
dard deviation (SD), or means ± standard error (SE),
and differences between groups were assessed with the
Student’s t-test. Categorical variables were represented
as percentages and were tested by the c
2 test. Hardy-
Weinberg equilibrium was also assessed using a c
2 test.
A generalised linear model was used to test the differ-
ences of obesity-related anthropometric and metabolic
traits between genotype groups of rs9939609 adjusted
for age and gender. To correct for multiple compari-
sons, the false discovery rate (FDR) approach was used
[21]. FDR analysis (0.05 as criteria) was applied for 15
adiposity measures simultaneously (number of tests: 15
for all, boys and girls, respectively). The association of
FTO rs9939609 with anthropometric and metabolic
traits as well as the per-allele effect size on these traits
were estimated using linear regression assuming an
additive genetic model. The genotypes were coded as 0,
1, or 2 corresponding to the number of copies of the
risk allele (A). Logistic regression was performed to esti-
mate the OR and 95% CI, which were calculated by
Woolf’s method. ORs for rs9939609 were computed
assuming an additive model using multiple logistic
regression adjusted for age and gender. The trend test
was used for assessing the association of the SNP with
obesity. The population attributable risk fraction was
estimated with data from the non-obese group and was
calculated as follows: PARP= 1-{1/[(1-f )
2+2f (1-f )r+f
2r
2]}, where r is the estimated OR and f is the risk allele
frequency [22]. The interaction of physical activity with
FTO rs9939609 allele was detected by linear regression
analysis. A general linear model was used to assess
effects of physical activity and the FTO rs9939609 allele
on BMI levels with an analysis of covariance
(ANCOVA) test assuming an additive model adjusted
for age and gender. The power calculation was per-
formed using Quanto software http://hydra.usc.edu/gxe/.
Our study had ≥ 75.96% to ≥ 99.84% power (enrolment
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obesity under an additive model, assuming a significance
of 0.05, an allele frequency of 0.149, and obesity preva-
lence of 10% in the school-age children of Beijing. Thus,
our case-control analysis had sufficient power to detect
similar effect sizes as described by Frayling et al. [11].
Statistical analyses were performed with SPSS, version
13.0 (SPSS, Inc., Chicago, Illinois), and p <0 . 0 5w a s
considered to be statistically significant.
Results
The clinical and biometrical characteristics of the study
populations are summarised in Table 1. The frequency of
the rs9939609 A allele was 0.121 in the present study,
and the genotypes of this SNP were in Hardy-Weinberg
equilibrium in both obese and non-obese groups (p >
0.1). Analyses were carried out to test the association of
rs9939609 with BMI and related anthropometric traits.
FDR analysis (0.05 significance level) was performed to
account for multiple testing. The mean values of BMI
were 21.7, 22.5 and 23.0 for TT, TA and AA genotypes,
respectively with a p value for trend of 1.39 × 10
-6,a n da
BMI increase of 0.79 (95%CI 0.47 to 1.10) kg/m
2 per A
allele, equivalent to 0.25 (95%CI 0.14 to 0.35) BMI-SDS
units (Table 2). The SNP is also associated with FMP,
WC, WHtR, SBP and DBP after adjusting for age and
gender(p < 0.05 for all traits). However, the association of
the SNP with SBP and DBP became weaker (both p >
0.05) after BMI was further adjusted. Moreover, we did
not observe a significant association of the SNP with
DBP, TC, TG, HDL-C, LDL-C and FPG after adjusting
for age and gender (all p > 0.05) (Table 2).
Logistic regression analyses were carried out to test
the null hypothesis of no association of the allelic state
of rs9939609 with the risk of obesity (Table 3). The
rs9939609 variant was significantly associated with obe-
sity (p-value for trend = 1.12 × 10
-3). Under an additive
model, the rs9939609-A allele was associated with an
increased risk of 1.29 (95%CI 1.11 to 1.50) after adjust-
ing for age and gender. The population attributable risk
fraction was lower in Chinese children and adolescents
(7.07%) than previously reported in European adult
populations (20.4%) [11].
We have also tested the association of rs9939609 with
BMI and the risk of obesity between boys and girls (see
Additional file 1). Association of rs9939609 with BMI
and related phenotypes such as weight, WC, WHtR and
FMP are as expected in males; however, there does not
appear to be a dose-dependent increase in BMI and
related traits in females of the AA genotype. Further
logistic analyses stratified for gender shows similar
trends for the association of rs9939609 with obesity risk
(see Additional file 2).
We detected an interaction between the FTO rs9939609
allele and physical activity that affects BMI levels
(pinteraction < 0.001). The effect of rs9939609 on BMI for
low, moderate and severe intensity of physical activity was
(0.95 ± 0.10), (0.77 ± 0.08) and (0.67 ± 0.05) kg/m
2,
Table 1 Baseline characteristics of the BCAMS study population (mean ± SD)
All Obese Non-obese p-value
a
n 3503 1229 2274
Boys (%) 1781 (50.8) 786 (64.0) 995 (43.8) < 0.001
Age (years) 12.4 ± 3.1 11.8 ± 2.9 12.7 ± 3.1 < 0.001
Height (cm) 152.3 ± 15.3 152.8 ± 14.6 152.1 ± 15.7 0.18
Weight (kg) 52.4 ± 18.6 63.6 ± 18.9 46.3 ± 15.4 < 0.001
Body mass index (kg/m
2) 21.9 ± 4.9 26.5 ± 3.7 19.4 ± 3.5 < 0.001
Body mass index-standard deviation score 1.21 ± 1.50 2.79 ± 1.01 0.35 ± 0.91 < 0.001
Waist circumference (cm) 72.4 ± 13.1 83.7 ± 10.9 66.3 ± 9.7 < 0.001
Waist-to-Height Ratio 0.47 ± 0.07 0.55 ± 0.05 0.44 ± 0.04 < 0.001
Fat mass percentage (%) 24.4 ± 8.5 30.9 ± 6.7 20.9 ± 7.3 < 0.001
Birth weight (g) 3355 ± 525 3423 ± 516 3317 ± 526 < 0.001
Systolic blood pressure (mmHg) 107.6 ± 13.9 114.3 ± 12.7 104.0 ± 13.2 < 0.001
Diastolic blood pressure (mmHg) 67.8 ± 10.0 71.9 ± 9.2 65.5 ± 9.8 < 0.001
Total cholesterol (mmol l
-1) 4.09 ± 0.82 4.09 ± 0.74 4.10 ± 0.87 0.76
Triglycerides (mmol l
-1) 1.03 ± 0.56 1.20 ± 0.63 0.94 ± 0.50 < 0.001
HDL-cholesterol (mmol l
-1) 1.40 ± 0.32 1.27 ± 0.26 1.47 ± 0.33 < 0.001
LDL-cholesterol (mmol l
-1) 2.55 ± 0.75 2.63 ± 0.66 2.51 ± 0.80 < 0.001
Fasting plasma glucose (mmol l
-1) 5.09 ± 0.62 5.16 ± 0.48 5.06 ± 0.68 < 0.001
Regular physical activity habit
b 56.3 53.1 58.0 < 0.001
a Quantitative variables between obese and non-obese groups were assessed with a Student’s t-test; categorical variables between groups were tested by a c
2
test.
b Regular physical activity was defined as participation in sports for at least 30 minutes per day and ≥ 3 days per week.
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carriers.
Discussion
Previous studies of the FTO gene identified a highly sig-
nificant association of the common SNP rs9939609 with
BMI in several European populations [11]. The associa-
tion was also significant in a seven-year follow-up study
in children ages 7 to 14 [11]. Subsequently, there were
several replication studies in children of different ances-
tries [23-25]. To our knowledge, this is the first replica-
tion study of rs9939609 associations in children of
Asian ancestry. Our results revealed significant associa-
t i o n sw i t hB M I ,W C ,W H t R ,F M P ,a n dw e i g h t ,b u tn o t
with height and birth weight. These associations indicate
that the genetic variant plays a vital role in body deposi-
tion in the developmental stages beyond birth. In addi-
tion, we didn’t observe statistically significant
associations of the SNP with BP, glucose status or lipid
traits. Furthermore, logistic regression analysis indicated
that the rs9939609 variant is an independent predictor
of obesity among children and adolescents. In our study,
we detected a 0.79 (95%CI 0.47 to 1.10) kg/m
2 BMI
increase per A allele, which was slightly higher than that
in European children (0.4 kg/m
2 increase per A allele).
Thus, the effect size of the rs9939609 A allele on the
risk of obesity is comparable to that in populations of
European children [11].
Table 2 Associations of the FTO rs9939609 variant with anthropometric and metabolic parameters (mean ± SE).
FTO rs9939609 genotype
a
TT TA AA p-value for
trend
a
Estimated change unit per A allele (95%
CI)
a
All(n) 2718 724 61
Height (cm) 152.3 ± 0.1 152.3 ± 0.3 153.6 ± 1.0 0.39 0.24 ((-0.33)-0.81)
Weight (kg) 51.9 ± 0.2 54.0 ± 0.5 55.6 ± 1.7 3.29 × 10
-5 b 2.01 (1.06-2.96)
Body mass index (kg/m
2) 21.7 ± 0.1 22.5 ± 0.2 23.0 ± 0.6 1.39 × 10
-6 b 0.79 (0.47-1.10)
Body mass index-standard deviation
score
1.15 ± 0.03 1.40 ± 0.05 1.61 ± 0.19 3.76 × 10
-6 b 0.25 (0.14-0.35)
Waist circumference (cm) 72.0 ± 0.2 73.7 ± 0.4 75.0 ± 1.4 2.26 × 10
-5 b 1.73 (0.93-2.54)
Waist-to-Height Ratio 0.472 ±
0.001
0.484 ±
0.002
0.488 ±
0.009
1.94 × 10
-5 b 0.01 (0.006-0.015)
Fat mass percentage (%) 24.1 ± 0.1 25.4 ± 0.3 25.6 ± 1.0 9.75 × 10
-5 b 1.16 (0.57-1.74)
Birth weight (g) 3358 ± 11 3345 ± 20 3342 ± 70 0.54 -12 ((-51)-27)
Systolic blood pressure (mmHg) 107.1 ± 0.2 109.2 ± 0.5 108.7 ± 1.6 1.41 × 10
-4 b
[0.14
c]
1.7 (0.8-2.6) [0.6((-0.2)-1.3)
c]
Diastolic blood pressure (mmHg) 67.6 ± 0.2 68.4 ± 0.3 69.3 ± 1.2 0.01
b [0.63
c] 0.8 (0.2-1.5)[0.1 ((-0.5)-0.8)
c]
Total cholesterol (mmol l
-1) 4.09 ± 0.02 4.10 ± 0.03 3.99 ± 0.10 0.69 -0.01 ((-0.07)-0.05)
Triglycerides (mmol l
-1) 1.03 ± 0.01 1.04 ± 0.02 1.03 ± 0.07 0.67 0.01 ((-0.03)-0.05)
HDL-cholesterol (mmol l
-1) 1.41 ± 0.01 1.38 ± 0.01 1.42 ± 0.04 0.11 -0.02 ((-0.04)-0.01)
LDL-cholesterol (mmol l
-1) 2.54 ± 0.01 2.58 ± 0.03 2.41 ± 0.10 0.83 0.01 ((-0.05)-0.06)
Fasting plasma glucose (mmol l
-1) 5.09 ± 0.01 5.10 ± 0.02 5.04 ± 0.08 0.98 0.001 ((-0.04)-0.04)
a Adjusted for age and gender.
b Indicates that the p-value remains significant after a false discovery rate control.
c Adjusted for age, gender and body mass index.
Table 3 Associations of FTO rs9939609 with obesity [OR (95% CI)].
Model 1
a Model 2
b
Obese(n = 1229) Non-obese(n = 2274) OR (95% CI) p-value for trend OR (95% CI) p-value for trend
FTO genotype
TT 915 1803 1 1
TA 288 436 1.30 (1.10-1.54) 1.31 (1.11-1.56)
AA 26 35 1.46 (0.88-2.45) 1.09 × 10
-3 1.46 (0.86-2.48) 1.12 × 10
-3
Additive model
T 2118 4042 1 1
A 340 506 1.28 (1.11-1.49) 9.26 × 10
-4 1.29 (1.11-1.50) 9.47 × 10
-4
a Model 1 is unadjusted.
b Model 2 is adjusted for age and gender.
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yielded inconsistent results [12-15]. This discrepancy
might partly be due to the low minor allele frequency
(MAF) of the variant allele, and therefore there is not
enough power to dissect the genetic contribution to
obesity. The MAF of rs9939609 was substantially lower
in the present study (12.1%) than in European popula-
tions (~45%) [11]. A meta-analysis combining all studies
in East Asian populations showed that the FTO
rs9939609 polymorphism is associated with obesity [26].
Other reasons might be differences in sample collection,
varying BMI standards, population admixture or envir-
onmental exposure. For example, Andreason et al. [27]
reported that physical activity might attenuate the
effects of the FTO rs9939609 variant on BMI. We also
found an interaction between the FTO variant and self-
reported physical activity in our study. However, the
study in Finnish children (n = 438) did not show an
interaction between the FTO variant and leisure-time
physical activity [28]. These conflicting results might be
due to low statistical power or inaccurate measurements
of physical activity. Therefore, population-based studies
with large sample sizes and a more direct measure of
physical activity are necessary to further investigate this
association.
Recently, Jacobsson et al. [29] reported a major gender
differences in the association of FTO gene with obesity-
related phenotypes in severely obese European children.
In our study, there was also a gender difference in the
association of this SNP with obesity, though the trends
were not consistent between our population and the
population of European children. Possible reasons for
gender differences may be the low MAF in children of
Chinese ancestry and small sample sizes in subgroups
stratified for gender. Other reasons could be fat distribu-
tion, deposition and accumulation in overall body com-
position are different between boys and girls [30].
Further large scale studies are needed to explore possi-
ble gender effects.
The mechanisms of how FTO variants influence BMI
and obesity-related traits are unclear. The FTO protein
was highly expressed in the brain (particularly the
hypothalamus), which is consistent with an important
role of the central nervous system in regulating weight
[31]. A recent report by a British group [23] indicated
that the rs9939609 variant influences energy-dense food
intake rather than regulation of energy expenditure in
children. Andreasen et al.[ 2 7 ]r e p o r t e dt h a tf a s t i n g
serum leptin levels were significantly elevated in
rs9939609 A allele carriers. Other studies have sup-
ported a central role of FTO on cerebrocortical insulin
sensitivity because individuals homozygous for the risk
allele have a reduced insulin response in the brain [32].
Future studies focusing on these phenotypes might help
clarify the mechanisms through which common variants
of the FTO gene and obesity are related.
The strengths of this study included the population-
based case-control study design and a high response
rate that minimised selection bias. In addition, our study
had sufficient power to detect the association of
rs9939609 with obesity in Chinese children and adoles-
cents. However, several limitations should also be noted.
First, the case-control study design does not allow for a
causality conclusion to be made. Second, the low MAF
of rs9939609 in this Chinese population impedes sub-
group analysis (e.g., gender) with sufficient power.
Third, only one SNP of FTO was measured in this
study, so it is unclear whether the identified association
i sd u et ot h i ss p e c i f i cs e q u e n c ev a r i a n to rt oa n o t h e r
variant in tight linkage disequilibrium with rs9939609
[28].
Conclusions
In conclusion, our findings detected an association
between the FTO rs9939609 variant and BMI and risk
of obesity among children and adolescents of Chinese
ancestry. The role of rs9939609 in mediating susceptibil-
ity to a higher BMI or an increased risk of obesity
among children requires further investigations including
detailed environmental exposure studies, especially with
respect to energy intake and food choices. In addition,
further understanding of the linkage disequilibrium pat-
tern of the FTO gene in different populations may aid
in the search of casual gene for obesity.
Additional material
Additional file 1: Associations of FTO rs9939609 with
anthropometric parameters (mean ± SE). stratified for gender.
Additional file 2: Associations of FTO rs9939609 with obesity
stratified for gender [OR (95% CI)].
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